<?xml version="1.0"?>
<rdf:RDF xmlns="http://purl.obolibrary.org/obo/arg/research.owl#"
     xml:base="http://purl.obolibrary.org/obo/arg/research.owl"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:vitro="http://vitro.mannlib.cornell.edu/ns/vitro/0.7#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <owl:Ontology rdf:about="http://purl.obolibrary.org/obo/arg/research.owl"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000111 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000111"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000112 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000112"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000114 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000114"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000115 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000117 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000117"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000118 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000118"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000119 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000119"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000412 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000412"/>
    


    <!-- http://vitro.mannlib.cornell.edu/ns/vitro/0.7#shortDef -->

    <owl:AnnotationProperty rdf:about="http://vitro.mannlib.cornell.edu/ns/vitro/0.7#shortDef"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/BFO_0000034 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/BFO_0000034"/>
    


    <!-- http://purl.obolibrary.org/obo/ERO_0000016 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/ERO_0000016"/>
    


    <!-- http://purl.obolibrary.org/obo/ERO_0001196 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/ERO_0001196">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gene knockdown function</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/OBI_0000377"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A perturb function that results in decreased expression levels of a target gene. This can be achieved through targeting a gene directly through gene knockout or modification of the its DNA sequence, or targeting of the mRNA product of a gene using technologies such as RNAi.</obo:IAO_0000115>
        <obo:IAO_0000118 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene repression function</obo:IAO_0000118>
        <obo:IAO_0000118 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene silencing function</obo:IAO_0000118>
        <obo:IAO_0000112 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Knockdown the function of a gene, to study the function of that gene.</obo:IAO_0000112>
        <obo:IAO_0000119 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PERSON: Matthew Brush</obo:IAO_0000119>
        <obo:IAO_0000117 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PERSON: Matthew Brush</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000120"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/ERO_0001197 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/ERO_0001197">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">RNA interference function</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/ERO_0001196"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A gene knockdown function that targets genes for post-transcriptional silencing through the RNA interference pathway.</obo:IAO_0000115>
        <obo:IAO_0000117 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PERSON: Matthew Brush</obo:IAO_0000117>
        <obo:IAO_0000119 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PERSON: Matthew Brush</obo:IAO_0000119>
        <obo:IAO_0000118 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">RNAi function</obo:IAO_0000118>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000123"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000104 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/IAO_0000104"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000368 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000368"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000369 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000369"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000370 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000370"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000371 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000371"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000372 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000372"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000374 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000374"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000375 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000375"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000376 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000376"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000377 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000377"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000379 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000379"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000383 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000383"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000387 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000387"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000392 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000392"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000393 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000393"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000395 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000395"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000397 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000397"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000401 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000401"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000453 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000453"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000946 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000946"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000960 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000960"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000961 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0000961"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0001036 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0001036"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0001043 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0001043"/>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0500000 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OBI_0500000"/>
    


    <!-- http://vivoweb.org/ontology/core#Equipment -->

    <owl:Class rdf:about="http://vivoweb.org/ontology/core#Equipment">
        <rdfs:label xml:lang="en">equipment</rdfs:label>
        <obo:IAO_0000112 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A network server is one example. Medical schools and research laboratories can list professional equipment, such as microscopes.</obo:IAO_0000112>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A physical object provided for specific purpose, task or occupation. </obo:IAO_0000115>
        <obo:IAO_0000112 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">server; Bruker Vector-33 FT-IR</obo:IAO_0000112>
    </owl:Class>
    


    <!-- http://vivoweb.org/ontology/scientific-research#Phase0ClinicalTrial -->

    <owl:Class rdf:about="http://vivoweb.org/ontology/scientific-research#Phase0ClinicalTrial">
        <rdfs:label xml:lang="en">phase 0 clinical trial</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/ERO_0000016"/>
        <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 0 Clinical Trial</vitro:shortDef>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 0 is a recent designation for exploratory, first-in-human trials  conducted in accordance with the United States Food and Drug Administration&apos;s (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies.  Phase 0 trials are also known as human microdosing  studies and are designed to speed up the development of promising drugs or imaging agents by establishing very early on whether the drug or agent behaves in human subjects as was expected from preclinical studies.</obo:IAO_0000115>
    </owl:Class>
    


    <!-- http://vivoweb.org/ontology/scientific-research#Phase1ClinicalTrial -->

    <owl:Class rdf:about="http://vivoweb.org/ontology/scientific-research#Phase1ClinicalTrial">
        <rdfs:label xml:lang="en">phase 1 clinical trial</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/ERO_0000016"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In Phase I trials, researchers test an experimental drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects</obo:IAO_0000115>
        <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 1 Clinical Trial</vitro:shortDef>
    </owl:Class>
    


    <!-- http://vivoweb.org/ontology/scientific-research#Phase2ClinicalTrial -->

    <owl:Class rdf:about="http://vivoweb.org/ontology/scientific-research#Phase2ClinicalTrial">
        <rdfs:label xml:lang="en">phase 2 clinical trial</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/ERO_0000016"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In Phase 2 trials, an experimental study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.</obo:IAO_0000115>
        <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 2 Clinical Trial</vitro:shortDef>
    </owl:Class>
    


    <!-- http://vivoweb.org/ontology/scientific-research#Phase3ClinicalTrial -->

    <owl:Class rdf:about="http://vivoweb.org/ontology/scientific-research#Phase3ClinicalTrial">
        <rdfs:label xml:lang="en">phase 3 clinical trial</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/ERO_0000016"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In Phase 3 trials, an experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.
</obo:IAO_0000115>
        <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 3 Clinical Trial</vitro:shortDef>
    </owl:Class>
    


    <!-- http://vivoweb.org/ontology/scientific-research#Phase4ClinicalTrial -->

    <owl:Class rdf:about="http://vivoweb.org/ontology/scientific-research#Phase4ClinicalTrial">
        <rdfs:label xml:lang="en">phase 4 clinical trial</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/ERO_0000016"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In Phase 4 trials, post marketing studies delineate additional information including the drug&apos;s or treatment&apos;s risks, benefits, and optimal use.</obo:IAO_0000115>
        <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 4 Clinical Trial</vitro:shortDef>
    </owl:Class>
</rdf:RDF>



<!-- Generated by the OWL API (version 3.4.8) http://owlapi.sourceforge.net -->

